GOTOVAX AB has a total of 15 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CYVAX INC, NOVARTIS VACCINES & DIAGNOSTICS SRL and CHIRON S.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | India | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Sweden | 1 | |
#9 | United States | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Peptides | |
#5 | Fermentation | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Lebens Michael | 12 |
#2 | Holmgren Jan | 11 |
#3 | Svennerholm Ann-Mari | 3 |
#4 | Tobias Joshua | 3 |
#5 | Harandi Ali M | 2 |
#6 | Michael Lebens | 1 |
#7 | Jan Holmgren | 1 |
Publication | Filing date | Title |
---|---|---|
EP2851089A1 | Cholera toxin a-like polypeptide useful as adjuvant component |